Galderma Labs patents expiration
1. Clobex patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7700081 | GALDERMA LABS | Foaming compositions for hair care |
Jan, 2022
(1 year, 8 months ago) | |
Drugs and Companies using CLOBETASOL PROPIONATE ingredient
Market Authorisation Date: 05 February, 2004
Treatment: Topical treatment of scalp psoriasis
Dosage: SHAMPOO;TOPICAL
How can I launch a generic of CLOBEX before it's drug patent expiration?
More Information on Dosage
CLOBEX family patents
2. Epiduo Forte patents expiration
EPIDUO FORTE's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9814690 | GALDERMA LABS | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec, 2022
(9 months ago) | |
| US8809305 | GALDERMA LABS | Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
Dec, 2022
(9 months ago) | |
| US8445543 | GALDERMA LABS | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Dec, 2022
(9 months ago) | |
| US8785420 | GALDERMA LABS | Combination/association of adapalene and benzoyl peroxide for treating acne lesions |
Dec, 2022
(9 months ago) | |
| US8936800 | GALDERMA LABS | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec, 2022
(9 months ago) | |
| US9381179 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(6 months ago) | |
| US8703820 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(6 months ago) | |
| US9387187 | GALDERMA LABS | Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(6 months ago) | |
| US8729127 | GALDERMA LABS | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar, 2023
(6 months ago) | |
Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient
Market Authorisation Date: 15 July, 2015
Treatment: Treatment of acne
Dosage: GEL;TOPICAL
How can I launch a generic of EPIDUO FORTE before it's drug patent expiration?
More Information on Dosage
EPIDUO FORTE family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic